Back to resultsMulligan Therapy Effects In Healthy Subjects With Induced Vertigo
Primary Purpose
Vertigo
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
sustained natural apophyseal glides
SHAM SNAG
Sponsored by
About this trial
This is an interventional health services research trial for Vertigo
Eligibility Criteria
Inclusion Criteria:
- Healthy subjects,
- Age 18-44 years.
Exclusion Criteria:
- Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants
- Hippoacusia
- Auditory diseases
- Peripheral or central vestibulopathies
- Cerviogenic dizziness
- Balance disorders
- Nistagmus
- Oculomotor nerve dysfunctions
- Migraine
- Cervical osteoporosis, lashing or fracture
- Discal cervical hernia
- Cervical neuropathy
- Psychriatic disorders
- Epilepsy
- Pregnancy
Sites / Locations
- CSEU La Salle
- Jose V Leon Hernandez
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Sham Comparator
No Intervention
Arm Label
SNAG GROUP
SHAM SNAG GROUP
CONTROL GROUP
Arm Description
The SNAG group received a treatment based on sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each, combined with active cervical extension.
The placebo SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension.
The control group did not receive any type of intervention, they only waited for four minutes, sat down on a chair
Outcomes
Primary Outcome Measures
vHIT (Video Head Impulse Test)
Detection of peripheral vestibular deficits and their recovery
Secondary Outcome Measures
Anxiety
state-trait anxiety was measured at the beginning of the study using the Spanish version of the trait-state anxiety inventory (STAI)
Full Information
NCT ID
NCT05118659
First Posted
October 19, 2021
Last Updated
November 3, 2021
Sponsor
Centro Universitario La Salle
1. Study Identification
Unique Protocol Identification Number
NCT05118659
Brief Title
Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo
Official Title
Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo. A Randomized And Controlled Clinic Study
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
February 3, 2018 (Actual)
Primary Completion Date
June 4, 2018 (Actual)
Study Completion Date
June 28, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centro Universitario La Salle
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This analysis aims to evaluate the immediate effect that cervical sustained natural apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric vestibular stimulation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vertigo
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SNAG GROUP
Arm Type
Experimental
Arm Description
The SNAG group received a treatment based on sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each, combined with active cervical extension.
Arm Title
SHAM SNAG GROUP
Arm Type
Sham Comparator
Arm Description
The placebo SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension.
Arm Title
CONTROL GROUP
Arm Type
No Intervention
Arm Description
The control group did not receive any type of intervention, they only waited for four minutes, sat down on a chair
Intervention Type
Procedure
Intervention Name(s)
sustained natural apophyseal glides
Other Intervention Name(s)
SNAG
Intervention Description
It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each
Intervention Type
Procedure
Intervention Name(s)
SHAM SNAG
Intervention Description
Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension
Primary Outcome Measure Information:
Title
vHIT (Video Head Impulse Test)
Description
Detection of peripheral vestibular deficits and their recovery
Time Frame
15 minutes
Secondary Outcome Measure Information:
Title
Anxiety
Description
state-trait anxiety was measured at the beginning of the study using the Spanish version of the trait-state anxiety inventory (STAI)
Time Frame
5 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
44 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy subjects,
Age 18-44 years.
Exclusion Criteria:
Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants
Hippoacusia
Auditory diseases
Peripheral or central vestibulopathies
Cerviogenic dizziness
Balance disorders
Nistagmus
Oculomotor nerve dysfunctions
Migraine
Cervical osteoporosis, lashing or fracture
Discal cervical hernia
Cervical neuropathy
Psychriatic disorders
Epilepsy
Pregnancy
Facility Information:
Facility Name
CSEU La Salle
City
Madrid
ZIP/Postal Code
28023
Country
Spain
Facility Name
Jose V Leon Hernandez
City
Madrid
ZIP/Postal Code
28023
Country
Spain
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data will only be treated by study researchers
Learn more about this trial
Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo
We'll reach out to this number within 24 hrs